Achieve Life Sciences, Inc. (ACHV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 216.67M |
| Enterprise Value | 210.69M |
| P/E Ratio | -4.54 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -44.79 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -6.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.6 |
| Return On Equity | -8.92 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -228,000 |
| EBITDA | -53.6M |
| Net Income | -54.65M |
| Diluted EPS | -1.25 |
| Total Cash | 187.3M |
| Total Cash/Share | 2 |
| Total Debt | 14.95M |
| Total Debt/Equity | -1.02 |
| Current Ratio | 0.95 |
| Book Value Per Share | -0.16 |
| 52-Week Change | 122.47 |
| 52-Week High | 8.64 |
| 52-Week Low | 2.62 |
| Moving Average 50 Days | 7 |
| Moving Average 200 Days | 5.2 |
| Average Volume | 1.87M |
| Shares Outstanding | 102.66M |
| % Held by Institutions | 88.57 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 31, 2020 |